tiprankstipranks
Trending News
More News >

Knight Therapeutics sees FY25 revenue C$390M-C$405M

Knight reconfirmed its financial guidance targets for 2025. Knight expects to generate between $390 million to $405 million in revenues and adjusted EBITDA to be approximately 13% of revenues.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1